CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | - USD | 100.0% |
| 2021 | -1.81 Million USD | -948.22% |
| 2020 | -173.4 Thousand USD | 96.62% |
| 2019 | -5.13 Million USD | 30.97% |
| 2018 | -7.44 Million USD | -10.18% |
| 2017 | -6.75 Million CAD | -201.83% |
| 2016 | -2.23 Million CAD | 0.0% |
| 2015 | - USD | 100.0% |
| 2014 | -126.64 Thousand CAD | 1.44% |
| 2013 | -128.49 Thousand CAD | 36.78% |
| 2012 | -203.24 Thousand CAD | -30.56% |
| 2011 | -155.66 Thousand CAD | -356.7% |
| 2010 | -34.08 Thousand CAD | 76.73% |
| 2009 | -146.49 Thousand CAD | 95.51% |
| 2008 | -3.26 Million CAD | -421.58% |
| 2007 | -626.01 Thousand CAD | 28.47% |
| 2006 | -875.13 Thousand CAD | -96.61% |
| 2005 | -445.11 Thousand CAD | -93.38% |
| 2004 | -230.18 Thousand CAD | 59.39% |
| 2003 | -566.84 Thousand CAD | -132.3% |
| 2002 | -244.01 Thousand CAD | -186.63% |
| 2001 | -85.12 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | -190.59 Thousand USD | -41.31% |
| 2022 Q4 | - USD | 100.0% |
| 2022 Q1 | -134.87 Thousand USD | 90.27% |
| 2022 Q3 | -258.59 Thousand USD | -35.68% |
| 2022 FY | - USD | 100.0% |
| 2021 Q2 | 147.69 Thousand USD | 143.96% |
| 2021 Q1 | -335.99 Thousand USD | -140.94% |
| 2021 Q3 | -243.51 Thousand USD | -264.88% |
| 2021 Q4 | -1.38 Million USD | -469.07% |
| 2021 FY | -1.81 Million USD | -948.22% |
| 2020 Q2 | -327.73 Thousand USD | 7.56% |
| 2020 Q3 | -311.74 Thousand USD | 4.88% |
| 2020 Q4 | 820.61 Thousand USD | 363.23% |
| 2020 FY | -173.4 Thousand USD | 96.62% |
| 2020 Q1 | -354.53 Thousand USD | 70.81% |
| 2019 FY | -5.13 Million USD | 30.97% |
| 2019 Q4 | -1.21 Million USD | -346.11% |
| 2019 Q3 | -272.21 Thousand USD | 83.42% |
| 2019 Q1 | -2 Million USD | 35.68% |
| 2019 Q2 | -1.64 Million USD | 18.31% |
| 2018 Q4 | -3.12 Million USD | -155.17% |
| 2018 Q3 | -1.22 Million CAD | 28.16% |
| 2018 Q2 | -1.7 Million CAD | -25.31% |
| 2018 Q1 | -1.35 Million CAD | -2.09% |
| 2018 FY | -7.44 Million USD | -10.18% |
| 2017 Q1 | -2.4 Million CAD | 0.0% |
| 2017 Q3 | -1.05 Million CAD | 37.66% |
| 2017 Q4 | -1.33 Million CAD | -25.72% |
| 2017 FY | -6.75 Million CAD | -201.83% |
| 2017 Q2 | -1.69 Million CAD | 29.23% |
| 2016 FY | -2.23 Million CAD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q3 | -41.17 Thousand CAD | -45.75% |
| 2015 Q4 | - USD | 100.0% |
| 2015 Q2 | -28.24 Thousand CAD | -5.08% |
| 2015 Q1 | -26.88 Thousand CAD | 11.02% |
| 2015 FY | - USD | 100.0% |
| 2014 Q2 | -39.45 Thousand CAD | -57.77% |
| 2014 Q3 | -33.95 Thousand CAD | 13.94% |
| 2014 Q4 | -30.21 Thousand CAD | 11.02% |
| 2014 FY | -126.64 Thousand CAD | 1.44% |
| 2014 Q1 | -25 Thousand CAD | 70.21% |
| 2013 Q2 | 26.58 Thousand CAD | 174.3% |
| 2013 FY | -128.49 Thousand CAD | 36.78% |
| 2013 Q4 | -83.95 Thousand CAD | -130.86% |
| 2013 Q3 | -36.36 Thousand CAD | -236.8% |
| 2013 Q1 | -35.77 Thousand CAD | 26.71% |
| 2012 FY | -203.24 Thousand CAD | -30.56% |
| 2012 Q3 | -57.04 Thousand CAD | 0.19% |
| 2012 Q4 | -48.81 Thousand CAD | 14.43% |
| 2012 Q1 | -37.8 Thousand CAD | 35.34% |
| 2012 Q2 | -57.15 Thousand CAD | -51.19% |
| 2011 Q1 | -46.31 Thousand CAD | -172.31% |
| 2011 Q2 | -24.32 Thousand CAD | 47.48% |
| 2011 Q3 | -31.12 Thousand CAD | -27.94% |
| 2011 FY | -155.66 Thousand CAD | -356.7% |
| 2011 Q4 | -58.46 Thousand CAD | -87.87% |
| 2010 Q4 | 64.04 Thousand CAD | 298.72% |
| 2010 Q3 | -32.23 Thousand CAD | 0.72% |
| 2010 FY | -34.08 Thousand CAD | 76.73% |
| 2010 Q2 | -32.46 Thousand CAD | 0.0% |
| 2009 FY | -146.49 Thousand CAD | 95.51% |
| 2008 Q3 | -3.57 Million CAD | -8773.21% |
| 2008 Q4 | 402.13 Thousand CAD | 111.24% |
| 2008 Q2 | -40.31 Thousand CAD | 23.76% |
| 2008 Q1 | -52.87 Thousand CAD | 72.61% |
| 2008 FY | -3.26 Million CAD | -421.58% |
| 2007 Q3 | -70.05 Thousand CAD | 73.9% |
| 2007 Q2 | -268.38 Thousand CAD | -315.12% |
| 2007 Q1 | -64.65 Thousand CAD | -114.34% |
| 2007 FY | -626.01 Thousand CAD | 28.47% |
| 2007 Q4 | -193.06 Thousand CAD | -175.58% |
| 2006 Q3 | -270.66 Thousand CAD | -248.09% |
| 2006 Q4 | -30.16 Thousand CAD | 88.86% |
| 2006 Q1 | -475.75 Thousand CAD | -294.18% |
| 2006 Q2 | -77.75 Thousand CAD | 83.66% |
| 2006 FY | -875.13 Thousand CAD | -96.61% |
| 2005 Q2 | -51.46 Thousand CAD | 36.14% |
| 2005 Q4 | -120.69 Thousand CAD | 35.23% |
| 2005 FY | -445.11 Thousand CAD | -93.38% |
| 2005 Q3 | -186.34 Thousand CAD | -262.09% |
| 2005 Q1 | -80.58 Thousand CAD | -13.91% |
| 2004 Q4 | -70.74 Thousand CAD | -65.69% |
| 2004 Q3 | -42.69 Thousand CAD | 6.76% |
| 2004 Q2 | -45.79 Thousand CAD | 30.33% |
| 2004 FY | -230.18 Thousand CAD | 59.39% |
| 2004 Q1 | -65.72 Thousand CAD | 84.43% |
| 2003 Q1 | -56.15 Thousand CAD | 53.88% |
| 2003 Q2 | -45.28 Thousand CAD | 19.35% |
| 2003 Q3 | -38.75 Thousand CAD | 14.43% |
| 2003 Q4 | -422.03 Thousand CAD | -989.06% |
| 2003 FY | -566.84 Thousand CAD | -132.3% |
| 2002 Q1 | -36.75 Thousand CAD | 0.0% |
| 2002 FY | -244.01 Thousand CAD | -186.63% |
| 2002 Q2 | -43.28 Thousand CAD | -17.75% |
| 2002 Q4 | -121.74 Thousand CAD | -176.92% |
| 2002 Q3 | -43.96 Thousand CAD | -1.57% |
| 2001 FY | -85.12 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioElectronics Corporation | -722.81 Thousand USD | 100.0% |
| IR-Med Inc. | -4.9 Million USD | 100.0% |
| Polarean Imaging plc | -11.88 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 100.0% |
| Avitar, Inc. | -2.25 Million USD | 100.0% |
| AVITA Medical, Inc. | -39.16 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 100.0% |
| Össur hf. | 58.38 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.51 Million USD | 100.0% |
| QHSLab, Inc. | -468.36 Thousand USD | 100.0% |
| Wellstar International, Inc. | -3.1 Million USD | 100.0% |
| Össur hf. | 58.38 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 100.0% |
| Escalon Medical Corp. | -125.26 Thousand USD | 100.0% |
| Aurora Spine Corporation | -1.68 Million USD | 100.0% |
| BrainsWay Ltd. | -4.19 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | -11.49 Million USD | 100.0% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 100.0% |
| Vivos Inc. | -2.89 Million USD | 100.0% |
| MicroPort Scientific Corporation | -477.62 Million USD | 100.0% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 100.0% |
| Nanomix Corporation | -12.33 Million USD | 100.0% |
| Theraclion SA | -3.67 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 100.0% |
| Positron Corporation | -1.63 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 100.0% |
| Lombard Medical, Inc. | -31.03 Million USD | 100.0% |
| ALR Technologies Inc. | -11.89 Million USD | 100.0% |
| Stratec SE | 14.42 Million USD | 100.0% |
| Vycor Medical, Inc. | -69.69 Thousand USD | 100.0% |
| Heart Tronics, Inc. | -13.32 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 46.44 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 100.0% |
| Ingen Technologies, Inc. | -5.06 Million USD | 100.0% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 100.0% |
| United American Healthcare Corporation | 723 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -3.61 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 100.0% |
| Urologix, Inc. | -7.6 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 100.0% |
| SS Innovations International, Inc. | -20.94 Million USD | 100.0% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 100.0% |
| Smith & Nephew plc | 263 Million USD | 100.0% |
| NIOX Group Plc | 13.64 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.45 Million USD | 100.0% |
| Broncus Holding Corporation | -28.09 Million USD | 100.0% |
| Brain Scientific Inc. | -12.34 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 100.0% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 100.0% |